BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Quris

Quris logo

Website
https://www.quris.ai/
Founded
2019
Publications
2

Quris is an Israel-based artificial intelligence (AI)-driven company, founded in 2019. After two funding rounds, with the last seed round in 2022, they raised a total $28M from multiple investors.
Quris aims to reduce the drug development costs by predicting the safety profiles of the drugs, for which they developed a Bio-AI Clinical Prediction Platform. The company claims to have a disruptive approach: instead of using few organs on chip, they train their algorithm with the data from patient-on-chip.


Posts Mentioning This Company

9 Innovative Life Sciences Companies to Watch in 2024

Feb. 13, 2024  
The biotech and pharmaceutical industries are entering 2024 amid a wave of innovation and technological advancement.  The biopharma field is increasingly influenced by the advent of cutting-edge technologies such as artificial intelligence (AI), organ-on-a-chip systems, and gene editing therapies promising more personalized and precise treatments for a variety of conditions.
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

The high-throughput system allows the analysis of thousands of drugs using patients-on-chip, where nanosensors assist with a continuous monitoring of the responses from each “organ representative” in a chip. Afterwards, the machine learning algorithm is trained with the data generated. Such a system allows to target the broad genomic diversity, which is achieved with multiple stem cell derived patient-on-chip-systems, for which Quris also collaborates with the New York Stem Cell Foundation.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.